Summary
MEDomics LLC, an Azusa-based company, has announced an innovative test allowing for early diagnosis of mitochondrial diseases, a group of disorders that can result in diabetes, blindness, deafness, migraine headaches, neurological dysfunction, muscle weakness and gastrointestinal symptoms.
Early diagnosis is especially important since these conditions are especially common in children, and treatment can often prevent serious complications or death.See the full content of this document
Extract
Medomics Creates Test for Diseases
The MEDomics MitoDx te...
See the full content of this document
Sponsored links
